The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,104.00
Bid: 12,104.00
Ask: 12,106.00
Change: 54.00 (0.45%)
Spread: 2.00 (0.017%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: ARM Leads Rising Market But Tour Operators Down

Mon, 18th Jul 2016 07:32

LONDON (Alliance News) - Stocks in London were higher shortly after the open Monday, with ARM Holdings shares rocketing to the top of the FTSE 100 after the company confirmed it has agreed to be acquired by SoftBank Group for GBP24.3 billion.

The FTSE 100 was up 0.7%, or 43.20 points at 6,713.14. The FTSE 250 was 1.0% higher at 16,894.26, while the AIM All-Share was adding 0.2% at 725.49.

Shares in ARM were up 45% at 1,729.00 pence. The FTSE 100-listed group, which makes chips used in smartphones and other connected devices, said Japanese technology and telecommunications conglomerate SoftBank will pay 1,700.00p per share.

That represents a 43% premium to ARM's closing price on Friday of 1,188.73p and a 42% premium to the all-time high that ARM shares hit in March 2015. The agreement earlier had been reported by the Financial Times newspaper.

SoftBank said is intends to maintain ARM's existing management team and brand and will maintain the company's headquarters in Cambridge. It plans to at least double ARM's UK headcount over the next five years and will boost the group's employee numbers internationally too. ARM's board said it unanimously recommends the offer.

Accendo Markets analyst Michael van Dulken said the positive open comes after the Turkish government took back control after a failed military coup. However, the analyst said that "this happening so soon after the tragic events in Nice last week simply adds to plentiful pre-existing geopolitical tension".

Van Dulken said investors will focus on the potential consequences the events in Turkey for both Middle East and European stability given the country's strategic geographic location.

Travel stocks were mixed. Air carriers International Consolidated Airlines Group and easyJet up 2.2% and 1.0%, respectively. However, travel operator TUI Group was down 1.6% and FTSE 250-listed Thomas Cook Group was the biggest mid-cap decliner, down 5.4%.

Shares in FTSE 100-listed AstraZeneca were up 0.6%. The drugmaker said its Tagrisso lung cancer treatment met its primary endpoint in phase 3 trials. AstraZeneca said the drug demonstrated superior progression-free survival rates in comparison to standard platinum-based doublet chemotherapy.

British Land was down 0.4%. The commercial property investor said that, while too early to assess the impact the UK's vote to leave the European Union will have on property markets in the UK, it does anticipates some extra caution from occupiers and investors.

Due to this, Liberum kept a Sell recommendation on British Land, but the broker acknowledged that it was a "robust quarter" for the real estate group.

British Land said that, in the first quarter to the end of June, it secured 256,000 square feet of retail lettings and renewals. Retail footfall in its properties was flat in the quarter, it said. Office lettings and renewals in the quarter totalled 25,000 square feet. Its said its occupancy rate is at 99% and confirmed its dividend for the first quarter of 7.30 pence per share, 3.0% higher year-on-year.

Ahead in the economic calendar on Monday, Bank of England Monetary Policy Committee member Martin Weale is due to make a speech at 0915 BST, and the Bundesbank's monthly report is at 1100 BST. Later in the day is the US National Association of Home Builders' housing market index.

Already released, the average asking price of a house in the UK was down 0.9% in July from the month before, property tracking website Rightmove said on Monday - coming in at GBP307,824. That followed a 0.8% increase in June. On a yearly basis, prices advanced 4.5%, slowing from 5.5% in the previous month.

Meanwhile, British retailers logged the steepest decline in footfall since early 2014, data published by the British Retail Consortium and Springboard showed. In June, footfall dropped 2.8% in June from last year, following a 0.3% rise in May. This was the sharpest fall since February 2014.

In Asia on Monday, the Tokyo market was closed for the Marine Day holiday. In China, the Shanghai Composite index fell 0.4%, while the Hang Seng index in Hong Kong continues up 0.7%.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.